These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 35104835)
21. Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350 [TBL] [Abstract][Full Text] [Related]
22. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901 [TBL] [Abstract][Full Text] [Related]
23. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern. Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385 [TBL] [Abstract][Full Text] [Related]
24. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
25. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Viana R; Moyo S; Amoako DG; Tegally H; Scheepers C; Althaus CL; Anyaneji UJ; Bester PA; Boni MF; Chand M; Choga WT; Colquhoun R; Davids M; Deforche K; Doolabh D; du Plessis L; Engelbrecht S; Everatt J; Giandhari J; Giovanetti M; Hardie D; Hill V; Hsiao NY; Iranzadeh A; Ismail A; Joseph C; Joseph R; Koopile L; Kosakovsky Pond SL; Kraemer MUG; Kuate-Lere L; Laguda-Akingba O; Lesetedi-Mafoko O; Lessells RJ; Lockman S; Lucaci AG; Maharaj A; Mahlangu B; Maponga T; Mahlakwane K; Makatini Z; Marais G; Maruapula D; Masupu K; Matshaba M; Mayaphi S; Mbhele N; Mbulawa MB; Mendes A; Mlisana K; Mnguni A; Mohale T; Moir M; Moruisi K; Mosepele M; Motsatsi G; Motswaledi MS; Mphoyakgosi T; Msomi N; Mwangi PN; Naidoo Y; Ntuli N; Nyaga M; Olubayo L; Pillay S; Radibe B; Ramphal Y; Ramphal U; San JE; Scott L; Shapiro R; Singh L; Smith-Lawrence P; Stevens W; Strydom A; Subramoney K; Tebeila N; Tshiabuila D; Tsui J; van Wyk S; Weaver S; Wibmer CK; Wilkinson E; Wolter N; Zarebski AE; Zuze B; Goedhals D; Preiser W; Treurnicht F; Venter M; Williamson C; Pybus OG; Bhiman J; Glass A; Martin DP; Rambaut A; Gaseitsiwe S; von Gottberg A; de Oliveira T Nature; 2022 Mar; 603(7902):679-686. PubMed ID: 35042229 [TBL] [Abstract][Full Text] [Related]
26. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Kannan S; Shaik Syed Ali P; Sheeza A Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466 [TBL] [Abstract][Full Text] [Related]
27. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency. Strobelt R; Broennimann K; Adler J; Shaul Y Viruses; 2023 May; 15(5):. PubMed ID: 37243215 [TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease. Ren W; Hong W; Yang J; Zou J; Chen L; Zhou Y; Lei H; Alu A; Que H; Gong Y; Bi Z; He C; Fu M; Peng D; Yang Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Ma X; Hu H; Cheng W; Dong H; Lei J; Chen L; Zhou X; Li J; Wang W; Lu G; Shen G; Yang L; Yang J; Wang Z; Jia G; Su Z; Shao B; Miao H; Yiu-Nam Lau J; Wei Y; Zhang K; Dai L; Lu S; Wei X J Clin Invest; 2024 Sep; 134(18):. PubMed ID: 39286971 [TBL] [Abstract][Full Text] [Related]
30. Why does the Omicron sub-variant spread faster than the original? Callaway E Nature; 2022 Feb; 602(7898):556-557. PubMed ID: 35177843 [No Abstract] [Full Text] [Related]
31. Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike. Fang L; Kang X; Hong Q; Xue C; Pan L; Chen J; Tang C; Sun L; Xu X; Yuan J; Du Y; Xu A ACS Appl Mater Interfaces; 2024 Jun; 16(23):29716-29727. PubMed ID: 38814480 [TBL] [Abstract][Full Text] [Related]
32. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages. Qing E; Gallagher T mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441 [TBL] [Abstract][Full Text] [Related]
34. The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage. Liang R; Ye ZW; Ong CP; Qin Z; Xie Y; Fan Y; Tang K; Poon VK; Chan CC; Yang X; Cao H; Wang K; Sun H; Hu B; Cai JP; Luo C; Chik KK; Chu H; Zheng Y; Yuen KY; Chan JF; Jin DY; Yuan S Emerg Microbes Infect; 2022 Dec; 11(1):2093-2101. PubMed ID: 35943779 [TBL] [Abstract][Full Text] [Related]
35. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters. Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653 [TBL] [Abstract][Full Text] [Related]
36. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model. O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415 [TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S. Pawłowski P Acta Biochim Pol; 2021 Dec; 69(1):263-264. PubMed ID: 34905671 [TBL] [Abstract][Full Text] [Related]
38. Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review. Tiecco G; Storti S; Degli Antoni M; Focà E; Castelli F; Quiros-Roldan E Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216104 [TBL] [Abstract][Full Text] [Related]
39. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809 [TBL] [Abstract][Full Text] [Related]